Groups Push to Reverse FDA on Zohydro
(MedPage Today) — A coalition of several advocacy groups wants to reinforce a message sent to FDA by other key policymakers: rescind approval of the powerful painkiller Zohydro. …read more
(MedPage Today) — A coalition of several advocacy groups wants to reinforce a message sent to FDA by other key policymakers: rescind approval of the powerful painkiller Zohydro. …read more